| |
| |
|
| Insider
Information: |
Slansky Richard B |
| Relationship: |
Chief Financial Officer |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
378,589 |
|
|
Indirect Shares
|
30,000 |
|
|
| Direct
Value |
$2,039,854 |
|
|
|
Indirect Value
|
$721,200 |
|
|
| Total
Shares |
408,589 |
|
|
| Total
Value |
$2,761,054 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Star Equity Holdings Ord Shs |
STRR |
Chief Financial Officer |
2012-04-10 |
29,039 |
2010-06-25 |
0 |
Premium* |
|
|
Genmark Diagnostics, Inc. |
GNMK |
Chief Financial Officer |
2014-05-08 |
79,534 |
2014-05-08 |
30,000 |
Premium* |
|
|
Oncosec Medical Incorporation |
ONCS |
Chief Financial Officer |
2018-07-05 |
270,016 |
2015-07-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-07-05 |
4 |
S |
$1.31 |
$8,823 |
D/D |
(6,725) |
270,016 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-29 |
4 |
S |
$1.38 |
$3,340 |
D/D |
(2,420) |
276,741 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-28 |
4 |
S |
$1.40 |
$4,948 |
D/D |
(3,532) |
279,161 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-27 |
4 |
S |
$1.37 |
$10,761 |
D/D |
(7,832) |
282,693 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-26 |
4 |
S |
$1.40 |
$14,921 |
D/D |
(10,673) |
290,525 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-25 |
4 |
S |
$1.41 |
$643 |
D/D |
(458) |
301,198 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-22 |
4 |
S |
$1.42 |
$9,515 |
D/D |
(6,710) |
301,656 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-21 |
4 |
S |
$1.40 |
$6,927 |
D/D |
(4,944) |
308,366 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-20 |
4 |
S |
$1.42 |
$35,416 |
D/D |
(24,906) |
313,310 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-19 |
4 |
S |
$1.36 |
$5,689 |
D/D |
(4,171) |
338,216 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-18 |
4 |
S |
$1.39 |
$17,482 |
D/D |
(12,613) |
342,387 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2018-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
200,000 |
355,000 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial Officer |
• – – |
2015-07-06 |
4 |
B |
$6.12 |
$918,000 |
D/D |
150,000 |
150,000 |
2.74 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial OfficerOfficer |
• – – |
2015-07-06 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Chief Financial OfficerOfficer |
• – – |
2015-06-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2014-05-08 |
4 |
AS |
$9.26 |
$21,319 |
D/D |
(2,302) |
79,534 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2014-03-11 |
4 |
AS |
$12.17 |
$20,439 |
D/D |
(1,680) |
81,836 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,937 |
83,516 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2014-02-07 |
4 |
AS |
$12.29 |
$10,302 |
D/D |
(838) |
66,579 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2013-11-06 |
4 |
AS |
$11.72 |
$7,735 |
D/D |
(660) |
66,359 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2013-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
67,019 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
21,624 |
52,019 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2012-06-26 |
4 |
B |
$4.20 |
$105,000 |
D/D |
25,000 |
55,395 |
2.74 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial Officer |
• – – |
2012-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
30,395 |
30,395 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Chief Financial OfficerOfficer |
• – – |
2012-04-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,000 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
